CONMED CORPORATION Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate
CONMED CORPORATION (CNMD) reported Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate of 5.65% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate · last filed 2026-02-17
- CONMED CORPORATION defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for the quarter ending 2009-03-31 was 5.97%.
- CONMED CORPORATION defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2025 was 5.65%, a 9.71% increase from fiscal 2024.
- CONMED CORPORATION defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2024 was 5.15%, a 4.81% decline from fiscal 2023.
- CONMED CORPORATION defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2023 was 5.41%, a 92.53% increase from fiscal 2022.
- CONMED CORPORATION defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2022 was 2.81%, a 15.16% increase from fiscal 2021.
| Period end | Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate 3 month | Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate 9 month | Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate 12 month |
|---|---|---|---|
| 2025-12-31 | 5.65% 10-K · filed 2026-02-17 | ||
| 2024-12-31 | 5.15% 10-K · filed 2026-02-17 | ||
| 2023-12-31 | 5.41% 10-K · filed 2026-02-17 | ||
| 2022-12-31 | 2.81% 10-K · filed 2025-02-18 | ||
| 2021-12-31 | 2.44% 10-K · filed 2024-02-28 | ||
| 2020-12-31 | 3.33% 10-K · filed 2023-02-21 | ||
| 2019-12-31 | 4.37% 10-K · filed 2022-02-22 | ||
| 2017-12-31 | 4.28% 10-K · filed 2018-02-26 | ||
| 2016-12-31 | 4.54% 10-K · filed 2018-02-26 | ||
| 2015-12-31 | 3.81% 10-K · filed 2018-02-26 | ||
| 2014-12-31 | 4.75% 10-K · filed 2017-02-27 | ||
| 2013-12-31 | 3.90% 10-K · filed 2016-02-23 | ||
| 2012-12-31 | 4.30% 10-K · filed 2015-02-23 | ||
| 2011-12-31 | 5.41% 10-K · filed 2014-02-24 | ||
| 2010-12-31 | 5.86% 10-K · filed 2013-02-25 | ||
| 2009-12-31 | 7.30% 10-K · filed 2012-02-28 | 5.97% 10-K · filed 2012-02-28 | |
| 2009-03-31 | 5.97% 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |